Cigna Corporation (CI) Chairman Sells $44,382.20 in Stock
Cigna Corporation (NYSE:CI) Chairman Isaiah Harris, Jr. sold 212 shares of the firm’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $209.35, for a total value of $44,382.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Cigna Corporation (NYSE CI) traded down $0.56 during midday trading on Wednesday, hitting $207.92. The stock had a trading volume of 1,038,705 shares, compared to its average volume of 1,348,088. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The stock has a market cap of $51,568.34, a P/E ratio of 20.15, a PEG ratio of 1.60 and a beta of 0.50. Cigna Corporation has a 12-month low of $131.26 and a 12-month high of $212.46.
Cigna (NYSE:CI) last posted its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.47. The company had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. Cigna had a net margin of 5.74% and a return on equity of 18.85%. Cigna’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.94 EPS. research analysts expect that Cigna Corporation will post 10.34 earnings per share for the current fiscal year.
Several analysts have recently commented on the company. BidaskClub upgraded Cigna from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 18th. Morgan Stanley raised their target price on Cigna from $188.00 to $195.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. BMO Capital Markets assumed coverage on Cigna in a research note on Monday, October 16th. They issued a “market perform” rating and a $210.00 target price for the company. Citigroup raised their target price on Cigna from $198.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Finally, Jefferies Group raised their target price on Cigna from $201.00 to $221.00 and gave the company a “buy” rating in a research note on Friday, October 13th. Three analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $201.50.
ILLEGAL ACTIVITY WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/12/13/cigna-corporation-ci-chairman-sells-44382-20-in-stock.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.